NCT06514729

Brief Summary

The objective of this study was to discuss the effects of different ventilation modes on patients with plasma inflammatory factor and respiratory function in patients with pulmonary removal.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 23, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

July 23, 2024

Status Verified

July 1, 2024

Enrollment Period

1.3 years

First QC Date

July 17, 2024

Last Update Submit

July 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical Pulmonary Infection Score

    The clinical pulmonary infection score index is mainly used to evaluate the severity of pulmonary infection, which involves many factors, including: body temperature, white blood cell count, tracheal secretions, oxygenation, X-ray chest X-ray, and the progress of pulmonary infiltrates. The maximum score is 12 points, and the severity of infection is directly proportional to its score.

    Within 15 days after surgery

Study Arms (3)

Group VCV+CPAP

EXPERIMENTAL

Ventilation side volume control ventilation+continuous positive pressure ventilation on the non ventilation side

Procedure: Adopting different ventilation modes during the operation

Group PCV+CPAP

EXPERIMENTAL

Ventilation side pressure control ventilation+continuous positive pressure ventilation on the non ventilation side

Procedure: Adopting different ventilation modes during the operation

Group PRVC+CPAP

EXPERIMENTAL

Ventilation side pressure regulated volume control ventilation+continuous positive pressure ventilation on the non ventilation side

Procedure: Adopting different ventilation modes during the operation

Interventions

The ventilation side adopts different ventilation modes combined with continuous positive pressure ventilation on the surgical side.

Group PCV+CPAPGroup PRVC+CPAPGroup VCV+CPAP

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Comprehensive examination and analysis of imaging, laboratory examination and other comprehensive examinations, the diagnosis is clear, which is in line with lobe resection surgical indications
  • Age 18-75 years old, the gender is not limited;
  • ASA grading Ⅰ \~ III level;
  • It is expected that the single lung ventilation time is ≥1 hours, and ≤3 hours

You may not qualify if:

  • Emergency surgery;
  • There is a taboos on the existence of systemic anesthesia;
  • There is a history of acute chronic upper respiratory infections in the past January;
  • Previous bronchial asthma, chronic obstructive pulmonary disease, bronchial dilatation, phthisis ,aspergillosis , acute respiratory distress syndrome or history of respiratory failure;
  • Merge the function of important organs such as heart, liver, and kidney;
  • There was a history of chest surgery and the history of trauma;
  • Preoperative lung function test obvious abnormal abnormal abnormalities (1 second of exhalation (FEV1) \<60%);
  • Patients refuse to participate in the clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Affiliated Hospital of Zunyi Medical University

Zunyi, Guizhou, 563000, China

RECRUITING

MeSH Terms

Conditions

Lung InjuryPneumonia

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesThoracic InjuriesWounds and InjuriesRespiratory Tract InfectionsInfections

Study Officials

  • Pan Jiamei

    Staff member of Department of Anesthesiology,Affiliated Hospital of Zunyi Medical University

    STUDY DIRECTOR
  • Zhang Hong

    Chief physician of Department of Anesthesiology,Affiliated Hospital of Zunyi Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The researchers in this study enrolled suitable patients using a random number table method before surgery, and then performed different intraoperative single lung ventilation modes according to the grouping after unblinding the patients upon entering the room. The postoperative follow-up personnel or data analysts are unaware of the grouping status.
Purpose
OTHER
Intervention Model
SEQUENTIAL
Model Details: This study was divided into 3 groups, one groups was ventilation side volume control ventilation+continuous positive pressure ventilation on the non ventilation side, the other groups was ventilation side volume control ventilation+continuous positive pressure ventilation on the non ventilation side; the other groups was ventilation side pressure regulated volume control ventilation+continuous positive pressure ventilation on the non ventilation side.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Anesthesiology resident,Affiliate Hospital of Zunyi Medical University

Study Record Dates

First Submitted

July 17, 2024

First Posted

July 23, 2024

Study Start

January 1, 2024

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

July 23, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

After the clinical trial , each groups and its clinical pulmonary Infection score were shared with other research teams.

Shared Documents
CSR
Time Frame
Data related to this trial can be shared for a total 6 months after publication.
Access Criteria
Contact the head of the study for approval

Locations